Molecular targets of isothiocyanates in cancer: recent advances

Parul Gupta1, Bonglee Kim, Sung-Hoon Kim

  • 1Department of Biomedical Sciences and Cancer Biology Center, Texas Tech University Health Sciences Center, Amarillo, TX, USA.

Insights

Isothiocyanates (ITCs) from cruciferous vegetables show promising anticancer effects. These natural compounds may prevent and treat cancer by inhibiting cell division and inducing apoptosis, with some ITCs progressing to clinical trials.

Area of Science:

  • Oncology
  • Nutritional Science
  • Pharmacology

Background:

  • Cancer is characterized by uncontrolled cell division due to aberrant signaling pathways.
  • Epidemiological studies suggest cruciferous vegetables reduce cancer risk.
  • Isothiocyanates (ITCs) are key active compounds in cruciferous vegetables, derived from glucosinolates.

Purpose of the Study:

  • To review the preventive and therapeutic effects of Isothiocyanates (ITCs) in cancer.
  • To summarize mechanistic and clinical data on ITC anticancer properties.

Main Methods:

  • Review of preclinical mechanistic studies on ITCs.
  • Analysis of available clinical trial data for ITCs.
  • Examination of epidemiological evidence linking cruciferous vegetables to cancer risk reduction.

Main Results:

  • ITCs demonstrate anticancer effects across various cancer types in preclinical studies.
  • Mechanisms include reactive oxygen species generation, cell cycle arrest, and apoptosis induction.
  • Several ITCs have advanced to clinical trials, showing promise as natural anticancer agents.

Conclusions:

  • Isothiocyanates (ITCs) represent a promising class of natural compounds for cancer prevention and therapy.
  • Further clinical investigation is warranted to fully establish the therapeutic potential of ITCs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Cancer Therapies02:49

Cancer Therapies

2.4K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K